Agios Pharmaceuticals | Der Umsatz



Sales Veränderung Datum
AbbVie USD 13.34B 1.76B 2025-03
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amgen USD 8.15B 936M 2025-03
Arrowhead Research USD 2.5M 2.5M 2024-12
Astellas Pharma JPY 459.29B 58.12B 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Bayer EUR 11.73B 1.76B 2024-12
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Daiichi Sankyo JPY 518.69B 33.85B 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Exelixis USD 566.76M 27.21M 2024-12
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Incyte USD 1.05B 128.7M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
Merck USD 15.53B 94M 2025-03
Moderna USD 108M 858M 2025-03
Novartis USD 13.15B 330M 2024-12
Novartis USD 13.56B 386M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Agios Pharmaceuticals Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.